Navigation Links
Video: Tasigna(R) Demonstrates Rapid Response as Initial Therapy in Life-Threatening Form of Leukemia
Date:12/8/2008

sing infants. Sexually active female patients taking Gleevec should use adequate contraception. If the patient does become pregnant while taking Gleevec, the patient should be advised of the potential hazard to the fetus.

Severe (NCI Grades 3/4) lab abnormalities -- including neutropenia (3.6%-48%), anemia (1%-42%), thrombocytopenia ( > 1%-33%), and hepatotoxicity (approx 5%) -- and severe adverse experiences (NCI Grades 3/4), including severe fluid retention (e.g., pleural effusion, pulmonary edema, and ascites) and superficial edema (1.3%-11%), hemorrhage (1.8%-19%), and musculoskeletal pain (2%-9%) were reported among patients receiving Gleevec*. Severe fluid retention appears to be dose-related, was more common in the advanced phase studies (where the dosage was 600 mg/day), and is more common in the elderly.

Severe congestive heart failure and left ventricular dysfunction have occasionally been reported. Most of the patients with reported cardiac events have had other co-morbidities and risk factors, including advanced age and previous medical history of cardiac disease. Patients with cardiac disease or risk factors for cardiac failure should be monitored carefully, and any patient with signs or symptoms consistent with cardiac failure should be evaluated and treated.

Dose adjustments may be necessary due to hepatotoxicity, other nonhematologic adverse reactions, or hematologic adverse reactions. Therapy with Gleevec was discontinued for drug-related adverse reactions in 2.4% to 5% of patients. Complete blood counts should be performed weekly for the first month, biweekly for the second month, and periodically thereafter as clinically indicated (for example, every 2-3 months).

A 25% decrease in the recommended dose should be used for patients with severe hepatic impairment. Patients with moderate renal impairment (CrCL = 20-39 mL/min) should receive a 50% decrease in the reco
'/>"/>

SOURCE Novartis
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine technology :

1. Video: New Research Discovers Independent Brain Networks Control Human Walking
2. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
3. Video: The Arizona Heart Institute Announces the Largest Worldwide Experience with Endoluminal Grafting to Treat Thoracic Aortic Aneurysms and Related Pathologies
4. Video: Actress and New Mom Keri Russell Joins PKIDs to Launch Silence the Sounds of Pertussis Campaign
5. Video: Quest Diagnostics Health Trends(TM) Report Shows Significant Gap in Care for Patients With Chronic Kidney Disease
6. Video: New Results From One of the Worlds Largest Breast Cancer Trials Herald Hope for Thousands of Women
7. VIDEO: Femara(R) helps protect against return of breast cancer even when treatment starts several years after completing tamoxifen therapy
8. Video: The Journal, Human Genetics, Publishes Results Supporting Interleukin Genetics Heart Health Test
9. Video: Major Independent Trial Demonstrates Significant Anticancer Benefit of Zometa(R) in Women With Early-Stage Breast Cancer
10. Video: Clinical Study Shows Liraglutide Reduced Blood Sugar, Weight, and Blood Pressure in Patients with Type 2 Diabetes
11. Video: Sanford Healths Journey to Cure Type 1 Diabetes Receives Major Boost
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/29/2015)... , May 29, 2015 Actinobac Biomed, ... originally funded with investments from Foundation Venture Capital Group ... Bio International 2015 as part of the Start-Up Stadium ... FVCG President James M. Golubieski . ... biotechnology industry, will be held in Philadelphia ...
(Date:5/29/2015)... , May 29, 2015  The annual customer ... physicians ranks Praxis EMR as #1 across all specialties. ... Market Research LLC conducts a poll of EHR users ... the results.    Praxis EMR topped ... the 18 performance based criteria used by Black Book. ...
(Date:5/29/2015)... , May 29, 2015 /CNW/ - Covalon Technologies Ltd. ... medical technologies company, is delighted to announce its ... 31, 2015, which includes revenue for three months ... of $264,340. Revenue from advanced wound care product sales ... 2015 increased 24% to $1,742,672 compared to $1,400,065 ...
Breaking Medicine Technology:Foundation Venture Capital Group Portfolio Companies to be Highlighted at Bio International in June 2Foundation Venture Capital Group Portfolio Companies to be Highlighted at Bio International in June 3Praxis EMR Ranks #1 for Physician Satisfaction in Black Book's 2015 Survey of Solo and Small Practices 2Covalon Announces Strong Second Quarter Results 2Covalon Announces Strong Second Quarter Results 3
... Reportlinker.com announces that a new market research ... Gastric Cancer - Global Drug Forecasts and ... http://www.reportlinker.com/p0479813/Gastric-Cancer---Global-Drug-Forecasts-and-Treatment-Analysis-to-2020-–-Volume-I-2011.html ... Analysis to 2020 – Volume I 2011 ...
... NEW YORK, April 12, 2011 Reportlinker.com announces that ... catalogue: Europe Nephrology and Urology Devices ... Europe Nephrology and Urology Devices Market ... GlobalData,s new report, "Europe Nephrology and Urology Devices ...
Cached Medicine Technology:Reportlinker Adds Gastric Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Volume I 2011 2Reportlinker Adds Gastric Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Volume I 2011 3Reportlinker Adds Gastric Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Volume I 2011 4Reportlinker Adds Gastric Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Volume I 2011 5Reportlinker Adds Gastric Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Volume I 2011 6Reportlinker Adds Gastric Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Volume I 2011 7Reportlinker Adds Gastric Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Volume I 2011 8Reportlinker Adds Gastric Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Volume I 2011 9Reportlinker Adds Gastric Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Volume I 2011 10Reportlinker Adds Gastric Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Volume I 2011 11Reportlinker Adds Gastric Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Volume I 2011 12Reportlinker Adds Gastric Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Volume I 2011 13Reportlinker Adds Gastric Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Volume I 2011 14Reportlinker Adds Gastric Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Volume I 2011 15Reportlinker Adds Gastric Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Volume I 2011 16Reportlinker Adds Gastric Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Volume I 2011 17Reportlinker Adds Gastric Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Volume I 2011 18Reportlinker Adds Gastric Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Volume I 2011 19Reportlinker Adds Gastric Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Volume I 2011 20Reportlinker Adds Gastric Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Volume I 2011 21Reportlinker Adds Gastric Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Volume I 2011 22Reportlinker Adds Europe Nephrology and Urology Devices Market Outlook to 2017 2Reportlinker Adds Europe Nephrology and Urology Devices Market Outlook to 2017 3Reportlinker Adds Europe Nephrology and Urology Devices Market Outlook to 2017 4Reportlinker Adds Europe Nephrology and Urology Devices Market Outlook to 2017 5Reportlinker Adds Europe Nephrology and Urology Devices Market Outlook to 2017 6Reportlinker Adds Europe Nephrology and Urology Devices Market Outlook to 2017 7Reportlinker Adds Europe Nephrology and Urology Devices Market Outlook to 2017 8Reportlinker Adds Europe Nephrology and Urology Devices Market Outlook to 2017 9Reportlinker Adds Europe Nephrology and Urology Devices Market Outlook to 2017 10Reportlinker Adds Europe Nephrology and Urology Devices Market Outlook to 2017 11Reportlinker Adds Europe Nephrology and Urology Devices Market Outlook to 2017 12Reportlinker Adds Europe Nephrology and Urology Devices Market Outlook to 2017 13Reportlinker Adds Europe Nephrology and Urology Devices Market Outlook to 2017 14Reportlinker Adds Europe Nephrology and Urology Devices Market Outlook to 2017 15
(Date:5/30/2015)... Thousands of aesthetic industry professionals converged ... by the American Society for Aesthetic Plastic Surgery (ASAPS). ... Zeltiq, the parent company of one of the fastest ... blazing growth, the one-of-a-kind device just sold its 2 ... currently in the news for gaining the FDA’s stamp ...
(Date:5/30/2015)... (PRWEB) May 30, 2015 One of ... lack of local healthcare options available. Often, the ruralness ... healthcare. For those in rural areas feeling the crunch ... health insurance or tired of paying high premiums and ... connecting patients with licensed physicians via the power of ...
(Date:5/30/2015)... ProIntro Magnify contains 30 self-animating and minimalistic Titles ... an elegant opening title to any Final Cut Pro ... design layouts. ProIntro Magnify is created exclusively for Final Cut ... use. Simply drag a preset into the FCPX ... the Inspector window then watch as ProIntro Magnify does the ...
(Date:5/30/2015)... (PRWEB) May 30, 2015 Nicole ... the Disability Income Associate (DIA) designation to further ... DIA designation is designed for insurance advisors, health ... further their knowledge and expertise associated with the ... the DIA designation is only the latest accomplishment ...
(Date:5/30/2015)... (PRWEB) May 30, 2015 Cyclist ... tour, “Wheels for the World 2015: Piles of ... to raise awareness about hemophilia and encourage individuals ... Life. , Save One Life supports nearly ... eleven developing countries through direct sponsorships, scholarships and ...
Breaking Medicine News(10 mins):Health News:Dr. Paul Vitenas Meets with Zeltiq President and CEO in Montreal 2Health News:Dr. Paul Vitenas Meets with Zeltiq President and CEO in Montreal 3Health News:Online USA Doctors Brings Healthcare to the Masses with New E-Consults 2Health News:Online USA Doctors Brings Healthcare to the Masses with New E-Consults 3Health News:Announcing the release of ProIntro Magnify from Pixel Film Studios. 2Health News:Secura Consultants Expands Disability Insurance Expertise 2Health News:Barry Haarde Cycles 4,000 Miles Across the USA for Hemophilia 2
... ARBOR, Mich. A new University of Michigan study in mice ... is also able to reduce the effects of graft-versus-host disease, ... had bone marrow transplants. , Plans are under way ... people as a new way to prevent graft-versus-host disease. Researchers ...
... Today, PRINCETON, N.J., July 10 ... alerts and travel security,information from renowned intelligence ... http://www.securassist.com . The redesigned site, launched today, ... for preventing and,handling travel security emergencies., ...
... July 10 Sommers Schwartz, P.C.,attorney Kenneth Watkins, ... medical malpractice and negligence case arising out of ... a gynecological exam,at a Henry Ford Hospital Detroit ... Hospital for their attorney fees and costs totaling ...
... women who are at lower risk for complications, ... the height of the uterus of a women pregnant with ... risk of having the babies born prematurely, a new report ... and women decide how many embryos should be transferred in ...
... An Indiana University School of Medicine program that partners ... physician-scientists has been given national recognition with a prestigious ... M.D./Ph.D. program, in which students receive the both degrees ... $1.25 million Medical Scientist Training Program award from the ...
... legislative victory for patient-centered medical home model, ... Centered,Primary Care Collaborative (PCPCC) released the following ... bill, which includes a provision,for a $100 ... model:, "The bill,s inclusion of additional ...
Cached Medicine News:Health News:Cancer drug shows promise against graft vs. host disease 2Health News:Cancer drug shows promise against graft vs. host disease 3Health News:Assist America's New SecurAssist Website Features Top Travel Security Information Powered by iJET 2Health News:Uterus Size May Predict Risk for Premature Twins After IVF 2Health News:NIH grant to strengthen IU and Purdue program to educate physician-scientists 2
... of guiding introducers includes Swartz™ Series, ... piece steerable, all designed for the ... varying curves and longer sheath lengths ... Jude Medical guiding introducers are designed ...
Lumenis 1000 Integrated Slit Lamp Fully-integrated biomicroscope slit lamp laser delivery system, complete with built-in LaserLink, parallel optics, magnification changer, micromanipulator and multi...
Novus 30001 A fully-integrated and powerful 532 nm Operating Room Photocoagulator with reliable DPSS technology and simplified operation using a touch screen interface and remote control....
... Selecta Trio The pinnacle ... Nd:YAG, diode-pumped solid-state (DPSS) 532 ... laser (SLT) and offering maximum ... The first and only Nd:YAG, ...
Medicine Products: